(3-262) Transition to Once Weekly Tirzepatide After Severe Nausea and Vomiting One Year After Successful Treatment with Both Semaglutide and Exenatide LAR Once Weekly

Monday, December 5, 2022

12:00 PM – 1:00 PM

Location: Bayside A, Level 1

Category: Case Report
Topic: Ambulatory Care

Co-Author(s): Zofia Dice, Jennifer Goldman

Primary Author(s)

Alina Hoxha
PharmD Candidate 2023
Massachusetts College of Pharmacy and Health Sciences - Boston, Massachusetts